Vibol Tan

Array ( [id] => 1504756 [patent_doc_number] => 06465634 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-15 [patent_title] => 'Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis' [patent_app_type] => B1 [patent_app_number] => 09/415900 [patent_app_country] => US [patent_app_date] => 1999-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 63 [patent_figures_cnt] => 68 [patent_no_of_words] => 71215 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/465/06465634.pdf [firstpage_image] =>[orig_patent_app_number] => 09415900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6735483 [patent_doc_number] => 20030013118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'METHODS OF DETERMINING RESISTANCE TO TREATMENT FOR HEPATITIS C VIRUS' [patent_app_type] => new [patent_app_number] => 09/406997 [patent_app_country] => US [patent_app_date] => 1999-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5852 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20030013118.pdf [firstpage_image] =>[orig_patent_app_number] => 09406997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6500049 [patent_doc_number] => 20020025512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-28 [patent_title] => 'FLUORESCENCE POLARIZATION- BASED DIAGNOSTIC ASSAY FOR EQUINE INFECTIOUS ANEMIA VIRUS' [patent_app_type] => new [patent_app_number] => 09/400564 [patent_app_country] => US [patent_app_date] => 1999-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5302 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20020025512.pdf [firstpage_image] =>[orig_patent_app_number] => 09400564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1474183 [patent_doc_number] => 06387685 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-14 [patent_title] => 'EHV-1 vectors' [patent_app_type] => B1 [patent_app_number] => 09/319976 [patent_app_country] => US [patent_app_date] => 1999-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3711 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/387/06387685.pdf [firstpage_image] =>[orig_patent_app_number] => 09319976 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1305730 [patent_doc_number] => 06617103 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-09 [patent_title] => 'Identification of a transforming fragment of herpes simplex type 2 and detection thereof in clinical specimens' [patent_app_type] => B1 [patent_app_number] => 09/202918 [patent_app_country] => US [patent_app_date] => 1999-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15212 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/617/06617103.pdf [firstpage_image] =>[orig_patent_app_number] => 09202918 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407601 [patent_doc_number] => 06300139 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-09 [patent_title] => 'FTCD antigen' [patent_app_type] => 1 [patent_app_number] => 9/373750 [patent_app_country] => US [patent_app_date] => 1999-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 14 [patent_no_of_words] => 5073 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/300/06300139.pdf [firstpage_image] =>[orig_patent_app_number] => 373750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1493401 [patent_doc_number] => 06403098 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-11 [patent_title] => 'Rotavirus vaccine formulations' [patent_app_type] => B1 [patent_app_number] => 09/366616 [patent_app_country] => US [patent_app_date] => 1999-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 24 [patent_no_of_words] => 8604 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/403/06403098.pdf [firstpage_image] =>[orig_patent_app_number] => 09366616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6755772 [patent_doc_number] => 20030003549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-02 [patent_title] => 'DETECTION OF HUMAN HEPATITIS B VIRUS SURFACE ANTIGEN MUTANTS BY SPECIFIC AMPLIFICATION AND ITS APPLICATION ON GENE CHIP' [patent_app_type] => new [patent_app_number] => 09/362394 [patent_app_country] => US [patent_app_date] => 1999-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4575 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20030003549.pdf [firstpage_image] =>[orig_patent_app_number] => 09362394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7964975 [patent_doc_number] => 06680054 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-20 [patent_title] => 'Macromolecular neuraminidase-binding compounds' [patent_app_type] => B1 [patent_app_number] => 09/308076 [patent_app_country] => US [patent_app_date] => 1999-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10782 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/680/06680054.pdf [firstpage_image] =>[orig_patent_app_number] => 09308076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1602008 [patent_doc_number] => 06432411 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-13 [patent_title] => 'Recombinant envelope vaccine against flavivirus infection' [patent_app_type] => B1 [patent_app_number] => 09/352387 [patent_app_country] => US [patent_app_date] => 1999-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 14278 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/432/06432411.pdf [firstpage_image] =>[orig_patent_app_number] => 09352387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4366147 [patent_doc_number] => 06287760 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Western blot test for the identification of antibodies specific against the HCMV virus' [patent_app_type] => 1 [patent_app_number] => 9/242391 [patent_app_country] => US [patent_app_date] => 1999-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 10 [patent_no_of_words] => 10924 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/287/06287760.pdf [firstpage_image] =>[orig_patent_app_number] => 242391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1265531 [patent_doc_number] => 06656481 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-02 [patent_title] => 'Vaccinal preparations' [patent_app_type] => B1 [patent_app_number] => 09/147773 [patent_app_country] => US [patent_app_date] => 1999-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4240 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/656/06656481.pdf [firstpage_image] =>[orig_patent_app_number] => 09147773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4301729 [patent_doc_number] => 06326137 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-04 [patent_title] => 'Hepatitis C virus protease-dependent chimeric pestivirus' [patent_app_type] => 1 [patent_app_number] => 9/344456 [patent_app_country] => US [patent_app_date] => 1999-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 11426 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/326/06326137.pdf [firstpage_image] =>[orig_patent_app_number] => 344456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6558480 [patent_doc_number] => 20020164582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'EBOLA VIRION PROTEINS EXPRESSED FROM VENEZUELAN EQUINE ENCEPHALITIS (VEE) VIRUS REPLICONS' [patent_app_type] => new [patent_app_number] => 09/337946 [patent_app_country] => US [patent_app_date] => 1999-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12644 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20020164582.pdf [firstpage_image] =>[orig_patent_app_number] => 09337946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4356649 [patent_doc_number] => 06255060 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-03 [patent_title] => 'Method of detecting protein by immuno RNA' [patent_app_type] => 1 [patent_app_number] => 9/337944 [patent_app_country] => US [patent_app_date] => 1999-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3766 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/255/06255060.pdf [firstpage_image] =>[orig_patent_app_number] => 337944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1580827 [patent_doc_number] => 06423528 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-23 [patent_title] => 'Herpes simplex virus-1 deletion variants and vaccines thereof' [patent_app_type] => B1 [patent_app_number] => 09/335039 [patent_app_country] => US [patent_app_date] => 1999-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7698 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/423/06423528.pdf [firstpage_image] =>[orig_patent_app_number] => 09335039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4375860 [patent_doc_number] => 06303336 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-16 [patent_title] => 'Herpes virus entry receptor protein' [patent_app_type] => 1 [patent_app_number] => 9/333279 [patent_app_country] => US [patent_app_date] => 1999-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 11958 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/303/06303336.pdf [firstpage_image] =>[orig_patent_app_number] => 333279 [rel_patent_id] =>[rel_patent_doc_number] =>)